keyboard_arrow_up

XTL Biopharmaceuticals Ltd. Product Pipeline H2 2014 Review Research Report

RnRMarketResearch.com adds “XTL Biopharmaceuticals Ltd. – Product Pipeline Review – 2014“ report to its research database.

The report “XTL Biopharmaceuticals Ltd. – Product Pipeline Review – 2014“ provides comprehensive information on the current therapeutic developmental pipeline of XTL Biopharmaceuticals Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Complete Report Details @ http://www.rnrmarketresearch.com/xtl-biopharmaceuticals-ltd-product-pipeline-review-2014-market-report.html .

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Purchase a copy of this report @  http://www.rnrmarketresearch.com/contacts/purchase?rname=248292 .

Scope

- The report provides brief overview of XTL Biopharmaceuticals Ltd. including business description, key information and facts, and its locations and subsidiaries

- The report reviews current pipeline of XTL Biopharmaceuticals Ltd.’s human therapeutic division and enlists all their major and minor projects

- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones

- Special feature on out-licensed and partnered product portfolio

- The report summarizes all the dormant and discontinued pipeline projects

- Latest company statement

- Latest news and deals relating to the XTL Biopharmaceuticals Ltd.’s pipeline products

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
XTL Biopharmaceuticals Ltd. Snapshot 5
XTL Biopharmaceuticals Ltd. Overview 5
Key Information 5
Key Facts 5
XTL Biopharmaceuticals Ltd. - Research and Development Overview 6
Key Therapeutic Areas 6
XTL Biopharmaceuticals Ltd. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
XTL Biopharmaceuticals Ltd. - Pipeline Products Glance 12
XTL Biopharmaceuticals Ltd. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
XTL Biopharmaceuticals Ltd. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
XTL Biopharmaceuticals Ltd. - Drug Profiles 15
edratide 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
SAM-101 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Recombinant Protein to Agonize Erythropoietin Receptor for Multiple Myeloma 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
PRT-0467 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
XTL Biopharmaceuticals Ltd. - Pipeline Analysis 19
XTL Biopharmaceuticals Ltd. - Pipeline Products by Target 19
XTL Biopharmaceuticals Ltd. - Pipeline Products by Route of Administration 20
XTL Biopharmaceuticals Ltd. - Pipeline Products by Molecule Type 21
XTL Biopharmaceuticals Ltd. - Pipeline Products by Mechanism of Action 22
XTL Biopharmaceuticals Ltd. - Recent Pipeline Updates 23
XTL Biopharmaceuticals Ltd. - Dormant Projects 24
XTL Biopharmaceuticals Ltd. - Discontinued Pipeline Products 25
Discontinued Pipeline Product Profiles 25
XTL-6865 25
BC-2125 25
bicifadine hydrochloride 25
edratide 25
XTL Biopharmaceuticals Ltd. - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28

List of Tables

XTL Biopharmaceuticals Ltd., Key Information 5
XTL Biopharmaceuticals Ltd., Key Facts 5
XTL Biopharmaceuticals Ltd. - Pipeline by Indication, 2014 7
XTL Biopharmaceuticals Ltd. - Pipeline by Stage of Development, 2014 8
XTL Biopharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2014 9
XTL Biopharmaceuticals Ltd. - Out-Licensed Products in Pipeline, 2014 10
XTL Biopharmaceuticals Ltd. - Out-Licensed Products/ Combination Treatment Modalities, 2014 11
XTL Biopharmaceuticals Ltd. - Phase II, 2014 12
XTL Biopharmaceuticals Ltd. - Phase I, 2014 13
XTL Biopharmaceuticals Ltd. - Preclinical, 2014 14
XTL Biopharmaceuticals Ltd. - Pipeline by Target, 2014 19
XTL Biopharmaceuticals Ltd. - Pipeline by Route of Administration, 2014 20
XTL Biopharmaceuticals Ltd. - Pipeline by Molecule Type, 2014 21
XTL Biopharmaceuticals Ltd. - Pipeline Products by Mechanism of Action, 2014 22
XTL Biopharmaceuticals Ltd. - Recent Pipeline Updates, 2014 23
XTL Biopharmaceuticals Ltd. - Dormant Developmental Projects,2014 24
XTL Biopharmaceuticals Ltd. - Discontinued Pipeline Products, 2014 25
XTL Biopharmaceuticals Ltd., Subsidiaries 26

List of Figures

XTL Biopharmaceuticals Ltd. - Pipeline by Top 10 Indication, 2014 7
XTL Biopharmaceuticals Ltd. - Pipeline by Stage of Development, 2014 8
XTL Biopharmaceuticals Ltd. - Monotherapy Products in Pipeline, 2014 9
XTL Biopharmaceuticals Ltd. - Pipeline by Top 10 Molecule Type, 2014 21

Browse more reports on Pharmaceuticals Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .